Skip to content
  • Sunday, 26 July 2026
  • 2:57 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Unlocking Business Foresight: How SciPy Transforms ‘What-If’ Scenario Planning with Advanced Statistical Simulation
Data Science & Bioinformatics

Unlocking Business Foresight: How SciPy Transforms ‘What-If’ Scenario Planning with Advanced Statistical Simulation

Evan Lee Salim May 27, 2026 0

In an era defined by rapid change and unprecedented uncertainty, businesses are increasingly challenged to anticipate future outcomes, assess risks,…

Read More
Advanced Materials Science

AI-Driven Natural Language Interface Synthegy Revolutionizes Chemical Synthesis Planning and Reaction Mechanism Prediction

Nila Kartika Wati May 13, 2026 0

The pursuit of molecular innovation stands as one of the most formidable intellectual challenges in modern science, requiring a sophisticated…

Read More
Pharmaceutical R&D

OZMOSI and Planview Forge Strategic Alliance to Revolutionize Pharmaceutical R&D Planning with AI-Powered Clinical Intelligence

Teuku Ryan Apr 24, 2026 0

OZMOSI and Planview have announced a significant partnership aimed at transforming how pharmaceutical organizations approach research and development (R&D) planning.…

Read More
Data Science & Bioinformatics

"Just in Time" World Modeling Supports Human Planning and Reasoning

Evan Lee Salim Apr 2, 2026 0

A recently published paper, "Just in Time" World Modeling Supports Human Planning and Reasoning, accessible via arXiv, introduces a novel…

Read More
Brain Tumors Induce Widespread Disruption of Calvarial Bone and Alteration of Skull Marrow Immune LandscapeCarnegie Scientists Uncover Exotic Superionic State of Carbon Hydride in the Deep Interiors of Ice Giant PlanetsPharma R&D Returns Soar to 7% Driven Almost Exclusively by GLP-1 Therapies, Deloitte Report RevealsCancer-Driving Mutations in Brain Immune Cells Linked to Alzheimer’s Disease Progression and New Diagnostic Pathways
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ